BioSpace

M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buy

After a frantic second quarter, M&A steadied with just under $30 billion across 22 total transactions, according to a BioSpace analysis.

By BioSpace

1 min read
M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buy
M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buy

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights